XML Financial LLC Decreases Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

XML Financial LLC lessened its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 34.4% in the fourth quarter, HoldingsChannel reports. The fund owned 15,307 shares of the pharmacy operator’s stock after selling 8,010 shares during the period. XML Financial LLC’s holdings in Walgreens Boots Alliance were worth $143,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of WBA. Regent Peak Wealth Advisors LLC bought a new position in shares of Walgreens Boots Alliance during the fourth quarter valued at about $125,000. M.E. Allison & CO. Inc. purchased a new position in Walgreens Boots Alliance during the 4th quarter valued at about $195,000. Ameritas Advisory Services LLC raised its position in Walgreens Boots Alliance by 5.6% during the 4th quarter. Ameritas Advisory Services LLC now owns 73,349 shares of the pharmacy operator’s stock valued at $684,000 after purchasing an additional 3,859 shares during the last quarter. HB Wealth Management LLC lifted its holdings in Walgreens Boots Alliance by 128.5% in the 4th quarter. HB Wealth Management LLC now owns 23,228 shares of the pharmacy operator’s stock worth $217,000 after buying an additional 13,061 shares during the period. Finally, Brooklyn Investment Group grew its position in shares of Walgreens Boots Alliance by 21.1% in the 4th quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator’s stock worth $44,000 after buying an additional 830 shares during the last quarter. 58.59% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

WBA has been the subject of a number of research analyst reports. Bank of America raised their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research note on Monday, January 13th. Barclays lifted their target price on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 16th. Evercore ISI increased their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday, January 13th. Jefferies Financial Group reduced their target price on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a report on Wednesday, October 23rd. Finally, UBS Group raised their target price on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research note on Thursday, October 17th. Four investment analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, Walgreens Boots Alliance currently has an average rating of “Hold” and an average target price of $13.27.

Walgreens Boots Alliance Trading Up 1.0 %

NASDAQ WBA opened at $11.74 on Friday. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $23.76. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The stock’s fifty day moving average price is $9.73 and its 200-day moving average price is $9.86. The stock has a market cap of $10.15 billion, a P/E ratio of -1.15, a P/E/G ratio of 1.43 and a beta of 0.64.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating the consensus estimate of $0.38 by $0.13. The company had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. Walgreens Boots Alliance’s revenue for the quarter was up 7.6% on a year-over-year basis. During the same period in the prior year, the firm posted $0.66 EPS. As a group, equities analysts forecast that Walgreens Boots Alliance, Inc. will post 1.59 EPS for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.